David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Saia
SAIA
$9.17B
| $5.65M | 0.01% |
90,122
-20,635
| -19% | -$1.14M |
|
|
CRCM
1252
DELISTED
CARE.COM, INC.
CRCM
| $5.65M | 0.01% |
355,315
+19,846
| +6% | +$294K |
|
1253
Rogers Corp
ROG
$2.23B
| $5.64M | 0.01% |
42,340
-19,066
| -31% | -$2.26M |
|
1254
PUT
Royal Gold
RGLD
$22.7B
| $5.64M | 0.01% |
65,500
+13,300
| +25% | +$1.15M |
|
1255
PUT
Seagate
STX
$186B
| $5.62M | 0.01% |
169,400
+62,400
| +58% | +$2.12M |
|
1256
Civeo
CVEO
$346M
| $5.61M | 0.01% |
164,156
-4,809
| -3% | -$123K |
|
|
GAP
1257
PUT
The Gap Inc
GAP
$7.25B
| $5.61M | 0.01% |
190,000
+40,000
| +27% | +$983K |
|
1258
NMI Holdings
NMIH
$3.41B
| $5.61M | 0.01% |
452,170
-88,372
| -16% | -$1.02M |
|
1259
Bankunited
BKU
$3.3B
| $5.6M | 0.01% |
157,548
-89,465
| -36% | -$3.01M |
|
1260
CALL
Credit Acceptance
CACC
$6.27B
| $5.6M | 0.01% |
+20,000
| New | +$5.25M |
|
|
1261
PUT
Credit Acceptance
CACC
$6.27B
| $5.6M | 0.01% |
20,000
+10,000
| +100% | +$2.63M |
|
1262
CALL
T-Mobile US
TMUS
$195B
| $5.58M | 0.01% |
90,500
| – | – |
|
|
BWLD
1263
DELISTED
Buffalo Wild Wings, Inc.
BWLD
| $5.58M | 0.01% |
+52,772
| New | +$5.87M |
|
1264
Cincinnati Financial
CINF
$26.3B
| $5.58M | 0.01% |
72,822
+44,907
| +161% | +$3.41M |
|
1265
PUT
PepsiCo
PEP
$194B
| $5.57M | 0.01% |
50,000
| – | – |
|
1266
CALL
Chemours
CC
$2.37B
| $5.57M | 0.01% |
110,000
-40,000
| -27% | -$1.89M |
|
1267
Eldorado Gold
EGO
$12.6B
| $5.56M | 0.01% |
506,360
-90,540
| -15% | -$987K |
|
1268
NN Inc
NNBR
$292M
| $5.55M | 0.01% |
191,550
-14,926
| -7% | -$405K |
|
1269
BCE
BCE
$22B
| $5.55M | 0.01% |
118,417
+19,071
| +19% | +$893K |
|
1270
Plains GP Holdings
PAGP
$5.38B
| $5.55M | 0.01% |
253,655
-594,005
| -70% | -$14.1M |
|
1271
PUT
Consolidated Edison
ED
$39.6B
| $5.54M | 0.01% |
68,700
| – | – |
|
1272
D.R. Horton
DHI
$42.2B
| $5.53M | 0.01% |
138,570
-245,567
| -64% | -$8.95M |
|
1273
CALL
Whirlpool
WHR
$2.65B
| $5.53M | 0.01% |
30,000
| – | – |
|
|
TBI
1274
Trueblue
TBI
$327M
| $5.51M | 0.01% |
245,607
-21,421
| -8% | -$484K |
|
|
XLNX
1275
DELISTED
Xilinx Inc
XLNX
| $5.51M | 0.01% |
77,831
-260,106
| -77% | -$17M |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.